Real-world comparative effectiveness of exenatide once weekly and liraglutide in patients with type 2 diabetes mellitus

被引：0
|
作者：
Saunders, W. [1 ]
Nguyen, H. Hiep [2 ]
Kalsekar, I. [2 ]
机构：
[1] Saunders Res, Charlotte, NC USA
[2] AstraZeneca, Ft Washington, MD USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
828
引用
收藏
页码：S335 / S336
页数：2
相关论文
共 50 条
  • [1] Real-World Comparative Effectiveness of Exenatide Once Weekly and Liraglutide in Patients with Type 2 Diabetes Mellitus
    Saunders, William
    Nguyen, Hiep
    Kalsekar, Iftekhar
    DIABETES, 2014, 63 : A310 - A310
  • [2] Comparative glycaemic effectiveness of dulaglutide vs liraglutide and exenatide once weekly in a US real-world setting
    Mody, R.
    Huang, Q.
    Yu, M.
    Patel, H.
    Zhao, R.
    Grabner, M.
    Lando, L. Fernandez
    DIABETOLOGIA, 2018, 61 : S363 - S363
  • [3] Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
    Saunders, William B.
    Nguyen, Hiep
    Kalsekar, Iftekhar
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2016, 9 : 217 - 223
  • [4] Exenatide once weekly in type 2 diabetes mellitus
    Bischoff, Lindsay A.
    Jabbour, Serge A.
    Miller, Jeffrey L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1297 - 1303
  • [5] Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece
    Tzanetakos, Charalampos
    Bargiota, Alexandra
    Kourlaba, Georgia
    Gourzoulidis, George
    Maniadakis, Nikos
    CLINICAL DRUG INVESTIGATION, 2018, 38 (01) : 67 - 77
  • [6] Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece
    Charalampos Tzanetakos
    Alexandra Bargiota
    Georgia Kourlaba
    George Gourzoulidis
    Nikos Maniadakis
    Clinical Drug Investigation, 2018, 38 : 67 - 77
  • [7] Real-World Adherence in Patients Aged=65 years with Type 2 Diabetes Mellitus for Exenatide QW, Liraglutide QD, and Exenatide BID
    Dufour, Robert
    Nguyen, Hiep
    Tarr, Amanda
    Bullano, Michael
    DIABETES, 2015, 64 : A294 - A295
  • [8] Predictors of Glycemic and Weight Response to Exenatide Once-Weekly in Patients with Type 2 Diabetes in a Real-World Setting
    Gorgojo-Martinez, Juan J.
    Brito-Sanfiel, Miguel A.
    Gargallo-Fernandez, Manuel A.
    Lisbona-Catalan, Arturo
    DIABETES, 2017, 66 : A297 - A297
  • [9] Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world Setting
    Di Dalmazi, Giulia
    Coluzzi, Sara
    Baldassarre, Maria P. A.
    Sorbo, Sofia Elena
    Dell'Aquila, Stefania
    Febo, Fabrizio
    Ginestra, Federica
    Graziano, Giusi
    Rossi, Maria C.
    Consoli, Agostino
    Formoso, Gloria
    CLINICAL THERAPEUTICS, 2020, 42 (09) : 1738 - +
  • [10] REAL-WORLD ADHERENCE IN MEDICARE PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) FOR EXENATIDE QW AND LIRAGLUTIDE QD
    Tarr, A.
    Nguyen, H.
    Dufour, R.
    Bullano, M.
    VALUE IN HEALTH, 2015, 18 (03) : A57 - A57
12345